TY - JOUR
T1 - miRNAs and isomiRs
T2 - Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex
AU - Scheper, Mirte
AU - Romagnolo, Alessia
AU - Besharat, Zein Mersini
AU - Iyer, Anand M.
AU - Moavero, Romina
AU - Hertzberg, Christoph
AU - Weschke, Bernhard
AU - Riney, Kate
AU - Feucht, Martha
AU - Scholl, Theresa
AU - Petrak, Borivoj
AU - Maulisova, Alice
AU - Nabbout, Rima
AU - Jansen, Anna C.
AU - Jansen, Floor E.
AU - Lagae, Lieven
AU - Urbanska, Malgorzata
AU - Ferretti, Elisabetta
AU - Tempes, Aleksandra
AU - Blazejczyk, Magdalena
AU - Jaworski, Jacek
AU - Kwiatkowski, David J.
AU - Jozwiak, Sergiusz
AU - Kotulska, Katarzyna
AU - Sadowski, Krzysztof
AU - Borkowska, Julita
AU - Curatolo, Paolo
AU - EPISTOP Consortium members
AU - Mills, James D.
AU - Aronica, Eleonora
N1 - Funding Information: This study was supported by the Framework Programme FP7/2007–2013 under the project EPISTOP (grant agreement 602391). S. Jozwiak, K. Kotulska, and J. Jaworski were partly financed by the EPIMARKER grant of the Polish National Center for Research and Development (STRATEGMED3/306,306/4/2016). A.E. acknowledges support by the Dutch Organization for Medical Sciences (ZonMw); Dutch Topsector of Life Sciences and Health (EPI-BIO-MIR LSHM17051-SGF) and EU H2020- Twinning project EpiEpiNet (No 952455). Publisher Copyright: © 2022 by the authors.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - Tuberous sclerosis complex (TSC) is a rare multi-system genetic disorder characterized by a high incidence of epilepsy and neuropsychiatric manifestations known as tuberous-sclerosis-associated neuropsychiatric disorders (TANDs), including autism spectrum disorder (ASD) and intellectual disability (ID). MicroRNAs (miRNAs) are small regulatory non-coding RNAs that regulate the expression of more than 60% of all protein-coding genes in humans and have been reported to be dysregulated in several diseases, including TSC. In the current study, RNA sequencing analysis was performed to define the miRNA and isoform (isomiR) expression patterns in serum. A Receiver Operating Characteristic (ROC) curve analysis was used to identify circulating molecular biomarkers, miRNAs, and isomiRs, able to discriminate the development of neuropsychiatric comorbidity, either ASD, ID, or ASD + ID, in patients with TSC. Part of our bioinformatics predictions was verified with RT-qPCR performed on RNA isolated from patients’ serum. Our results support the notion that circulating miRNAs and isomiRs have the potential to aid standard clinical testing in the early risk assessment of ASD and ID development in TSC patients.
AB - Tuberous sclerosis complex (TSC) is a rare multi-system genetic disorder characterized by a high incidence of epilepsy and neuropsychiatric manifestations known as tuberous-sclerosis-associated neuropsychiatric disorders (TANDs), including autism spectrum disorder (ASD) and intellectual disability (ID). MicroRNAs (miRNAs) are small regulatory non-coding RNAs that regulate the expression of more than 60% of all protein-coding genes in humans and have been reported to be dysregulated in several diseases, including TSC. In the current study, RNA sequencing analysis was performed to define the miRNA and isoform (isomiR) expression patterns in serum. A Receiver Operating Characteristic (ROC) curve analysis was used to identify circulating molecular biomarkers, miRNAs, and isomiRs, able to discriminate the development of neuropsychiatric comorbidity, either ASD, ID, or ASD + ID, in patients with TSC. Part of our bioinformatics predictions was verified with RT-qPCR performed on RNA isolated from patients’ serum. Our results support the notion that circulating miRNAs and isomiRs have the potential to aid standard clinical testing in the early risk assessment of ASD and ID development in TSC patients.
KW - autism spectrum disorder
KW - biomarkers
KW - epilepsy
KW - intellectual disability
KW - serum
KW - tuberous sclerosis complex
UR - http://www.scopus.com/inward/record.url?scp=85137372591&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/biomedicines10081838
DO - https://doi.org/10.3390/biomedicines10081838
M3 - Article
C2 - 36009385
SN - 2227-9059
VL - 10
JO - Biomedicines
JF - Biomedicines
IS - 8
M1 - 1838
ER -